Reaction Details Report a problem with these data
Target
Free fatty acid receptor 1
Ligand
BDBM300839
Substrate
n/a
Meas. Tech.
GPR40 Calcium Flux Assay
EC50
17.0±n/a nM
Citation
 Huang, H; Kuo, G; Player, MR; Yang, S; Zhang, Y Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes US Patent  US10131648 Publication Date 11/20/2018 
Target
Name:
Free fatty acid receptor 1
Synonyms:
FFAR1 | FFAR1_HUMAN | G-protein Coupled Receptor 40 | GPR40
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
31473.32
Organism:
Homo sapiens (Human)
Description:
O14842
Residue:
300
Sequence:
MDLPPQLSFGLYVAAFALGFPLNVLAIRGATAHARLRLTPSLVYALNLGCSDLLLTVSLPLKAVEALASGAWPLPASLCPVFAVAHFFPLYAGGGFLAALSAGRYLGAAFPLGYQAFRRPCYSWGVCAAIWALVLCHLGLVFGLEAPGGWLDHSNTSLGINTPVNGSPVCLEAWDPASAGPARFSLSLLLFFLPLAITAFCYVGCLRALARSGLTHRRKLRAAWVAGGALLTLLLCVGPYNASNVASFLYPNLGGSWRKLGLITGAWSVVLNPLVTGYLGRGPGLKTVCAARTQGGKSQK
  
Inhibitor
Name:
BDBM300839
Synonyms:
2-((1r,3r)-3-Hydroxy-1-(4-((3- (2-methyl-4-((tetrahydro-2H- pyran-4-yl)oxy)phenyl) benzo[b]thiophen-5- yl)methoxy)phenyl)cyclobutyl) acetic acid | US10131648, Compound 37 | US10195178, Compound 37 | US9790198, Compound 37
Type:
Small organic molecule
Emp. Form.:
C33H34O6S
Mol. Mass.:
558.684
SMILES:
Cc1cc(OC2CCOCC2)ccc1-c1csc2ccc(COc3ccc(cc3)[C@@]3(CC(O)=O)C[C@H](O)C3)cc12 |r,wU:29.31,wD:35.38,(-2.44,.18,;-3.92,-.22,;-4.32,-1.7,;-5.81,-2.1,;-6.21,-3.59,;-7.7,-3.99,;-8.78,-2.9,;-10.27,-3.3,;-10.67,-4.79,;-9.58,-5.87,;-8.09,-5.48,;-6.9,-1.01,;-6.5,.47,;-5.01,.87,;-4.61,2.36,;-5.86,3.27,;-5.38,4.73,;-3.84,4.73,;-2.81,5.87,;-1.31,5.55,;-.83,4.09,;.66,3.69,;1.06,2.2,;2.54,1.81,;2.94,.32,;4.43,-.08,;5.52,1.01,;5.12,2.5,;3.63,2.89,;7.01,.61,;8.09,1.7,;9.58,1.3,;10.67,2.39,;9.98,-.19,;8.34,-.16,;7.57,-1.49,;7.97,-2.98,;6.24,-.72,;-1.86,2.95,;-3.37,3.27,)|
Structure:
Search PDB for entries with ligand similarity: